Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-regulating NFκB activity within two separate high-throughput screens of NFκB activation
- 30 October 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (1) , 329-335
- https://doi.org/10.1016/j.bmcl.2007.10.100
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- A Cell-Based Assay for IκBα Stabilization Using A Two-Color Dual Luciferase-Based SensorASSAY and Drug Development Technologies, 2007
- Nuclear factor-κB: a transcription factor for all seasonsEmerging Therapeutic Targets, 2007
- Integrating cell-signalling pathways with NF-κB and IKK functionNature Reviews Molecular Cell Biology, 2007
- Inhibitors of NF-κB signaling: 785 and countingOncogene, 2006
- Introduction to NF-κB: players, pathways, perspectivesOncogene, 2006
- Transcriptional regulation via the NF-κB signaling moduleOncogene, 2006
- A loss-of-function RNA interference screen for molecular targets in cancerNature, 2006
- Prostate Stem Cell Antigen Is Overexpressed in Prostate Cancer MetastasesClinical Cancer Research, 2005
- Inhibitor of nuclear factor-κB induction by cAMP antagonizes interleukin-1-induced human macrophage-colony-stimulating-factor expressionBiochemical Journal, 2001
- Novel Inhibitors of Cytokine-induced IκBα Phosphorylation and Endothelial Cell Adhesion Molecule Expression Show Anti-inflammatory Effects in VivoJournal of Biological Chemistry, 1997